- Home
- WMK vs KOD Comparison
WMK vs KOD Comparison
Compare WMK & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WMK | KOD |
|---|---|---|
| Founded | 1912 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | WMK | KOD |
|---|---|---|
| Price | $73.97 | $21.83 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $28.29 |
| AVG Volume (30 Days) | 116.4K | ★ 656.9K |
| Earning Date | 02-20-2026 | 03-26-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ 6.99 | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | ★ $4,894,832,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.94 | ★ N/A |
| Revenue Growth | ★ 2.20 | N/A |
| 52 Week Low | $61.53 | $1.92 |
| 52 Week High | $90.23 | $31.18 |
Technical Indicators
Market Signals| Indicator | WMK | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 62.28 | 43.59 |
| Support Level | $70.48 | $21.20 |
| Resistance Level | $75.45 | $23.27 |
| Average True Range (ATR) | 1.80 | 1.98 |
| MACD | -0.05 | -0.22 |
| Stochastic Oscillator | 65.08 | 29.27 |
Price Performance
Historical ComparisonAbout WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.